Carlos Bonilla
Corporate Officer/Principal chez Carlos J. Bonilla & Associates PL
Fortune : 1 M $ au 31/05/2024
Postes actifs de Carlos Bonilla
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Carlos J. Bonilla & Associates PL | Corporate Officer/Principal | 12/05/2011 | - |
Historique de carrière de Carlos Bonilla
Anciens postes connus de Carlos Bonilla
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
XenaCare Holdings, Inc.
 XenaCare Holdings, Inc. Pharmaceuticals: OtherHealth Technology XenaCare Holdings, Inc. engages in the formulation, marketing and distribution of nutrition supplement products. It offers Cobroxin for pain medication, XenaCor and XenaTri for cardiovascular health, XenaZyme Plus supports digestion and SunPill for skin protection against ultraviolet rays. The company was founded by Alan P. Xenakis in June 2005 and is headquartered in Tampa, FL. | Directeur/Membre du Conseil | 25/03/2011 | - |
| Independent Dir/Board Member | 24/03/2011 | - |
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
XenaCare Holdings, Inc.
XenaCare Holdings, Inc. Pharmaceuticals: OtherHealth Technology XenaCare Holdings, Inc. engages in the formulation, marketing and distribution of nutrition supplement products. It offers Cobroxin for pain medication, XenaCor and XenaTri for cardiovascular health, XenaZyme Plus supports digestion and SunPill for skin protection against ultraviolet rays. The company was founded by Alan P. Xenakis in June 2005 and is headquartered in Tampa, FL. | Health Technology |
| Carlos J. Bonilla & Associates PL |
- Bourse
- Insiders
- Carlos Bonilla
- Expérience
